Westlake Chemical Partners LP (NYSE:WLKP – Get Free Report) shares reached a new 52-week high on Monday after the company announced better than expected quarterly earnings. The stock traded as high as $25.04 and last traded at $24.73, with a volume of 12644 shares trading hands. The stock had previously closed at $24.22.
The basic materials company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.36 by $0.07. Westlake Chemical Partners had a net margin of 5.40% and a return on equity of 7.31%.
Westlake Chemical Partners Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 25th. Shareholders of record on Friday, February 7th will be given a dividend of $0.4714 per share. The ex-dividend date of this dividend is Friday, February 7th. This represents a $1.89 dividend on an annualized basis and a yield of 7.67%. This is an increase from Westlake Chemical Partners’s previous quarterly dividend of $0.47. Westlake Chemical Partners’s dividend payout ratio is presently 107.43%.
Hedge Funds Weigh In On Westlake Chemical Partners
Westlake Chemical Partners Stock Performance
The company has a current ratio of 4.53, a quick ratio of 4.46 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $866.00 million, a price-to-earnings ratio of 14.04 and a beta of 1.09. The stock’s 50 day moving average price is $23.73 and its two-hundred day moving average price is $23.08.
About Westlake Chemical Partners
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company’s ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis.
Featured Stories
- Five stocks we like better than Westlake Chemical Partners
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Beaten Down Healthcare Stocks Recovering in 2025
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- These 3 Unusual ETFs Have Dominated the S&P 500’s Performance YTD
- Low PE Growth Stocks: Unlocking Investment Opportunities
- UnitedHealth’s RSI Suggests It Is Extremely Oversold
Receive News & Ratings for Westlake Chemical Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Westlake Chemical Partners and related companies with MarketBeat.com's FREE daily email newsletter.